Table of contents
Declaratiori .•..................................................................................................................................... i
Approval ......................................................................................................................................... ii
Dedication ...................................................................................................................................... iii
Acknowledgement ................................ : ........................... , ............................................................ iv
List of Abbreviations ...................................................................................................................... v
Operational definitions ......................... : ........................... : ............................................................. vi
Table of contents ........................................................................................................................... vii
List of figures .............................................................................................. xi
List of tables ..................................................... xii
Abstract: ..................................................... xiii
Chapter One: Introduction .............................................................................................................. 1
1.1Background'ofthe study ............................................................................................................ I
1.2 Problem statement. .................................................................................................................... 5
1.3 Purpose of the.study .................................................................................................................. 5
1.4 Specific objectives .................................................................................................................... 6
1.5 Research questions ..................................................................................................................... 6
1.6 Justification of the study ........................................................................................................... 6
1. 7 Significance of the study ........................................................................................................... 7
1.8 Conceptual framework .............................................................................................................. 8
1. 9 Study scope ................................................................. 9
1. 9.1 Content scope ......................................................................................................................... 9
1.9.2 Geographical. scope ................................................................................................................. 9
1.9.3 Time scope : ........................................... 9
Chapter Two: Literature Review .................................................................................................. 10
2.0 Introduction ........................................................... 10
2.1 Prevalence of thrombocytopenia in pregnancy ....................................................................... 10
2.2 hnmediate maternal complications and their relationship with thrombocytopenia ................ II
2.3 Social demographic, obstetrics and medical factors as.sociated with thrombocytopenia in pregnancy ...................... 13
Chapter Three: Methodology ........................................................................................................ 16
3.1 Study Design ........................................................................................................................... 16
3.2 Study· site and setting ........ : ..................................................................................................... 16
3.3 Studypopulation ..................................................................... : ............................................... 16
3.4 Selection criteria ..................................................................................................................... 16
3.4.1 Inclusion criteria .................................................................................................................. 16 . 3.4.2 Exclusion criteria ................................................................................................................. 16
3.5 Sample size ............................................................................................................................. 17
3.5.1 Sample size determination .................................................................................................... 17
3.6 Sampling technique ................................................................................................................. 17
Figure 2: Flow Chat for the participant recruitment and data collection ...................................... 18
3.7 Data collection instruments ............. , ....................................................................................... 19
3.8 Procedure ................................................................................................................................ 19
3.8.2.1 History taking .................................................................................................................... 19
3.8.2.2 Examination .............................•........................................................................................ 19
3.9 Validity of data ~ollection i,nstruments ................................................................................... 20
3.10 Reliability o( data collection instruments· ............................................................................. 2()
3.11 Sample processing and analysis ............................................................................................ 20
3.12 Data an.alysis plan ................................................................................................................. 20
3.13 Fea,sibility.ofthe study ........................................................ : ................................................. 21
3.14 Quality control ...................................................................................................................... 21
3.15 Ethical considerations ........................................................................................................... 21
3.15 .1 Informed consent and respect for participants ................................................................... 21
3.15.2 Risk and adverse event to study participants ......... ~ ........................................................... 21
3.15.3 Benefits ofthe research ...................................................................................................... 22
3.15.4 Privacy and confidentiality .................................... ." ........................................................... 22
3.15.5 Sampling technique ............................................................................................................ 22
3.15.6 Incentives and reimbursement ........................................................................................... 22
3.15. 7 Approval procedure ........................................................................................................... 22
3.15. 8 Respect for community ~d feedback ................................................................................ 23
Chapter Four: Presentation and Interpretation ofResults ............................................................. 24
4.1 Participants Characteristics ..................................................................................................... 24
4.1.1 Social demographic characteristics of study participants .. : ................................................. 24
4.1.2 Obstetrics and medical characteristic of study participants ................................................. 25
4.2 The overall prevalence, age specific prevalence and severity of thrombocytopenia among women who delivered at KIU-11I .................. 26
4.3 The relationship between immediate maternal complications and thrombocytopenia among women delivering at KIU -11I ........................ 27
4.4 Bivariate analysis of social demographic, obstetrics and medical factors associated with thrombocytopenia among women delivering at KIU -11I ... 28
4.5 Multivariate analysis of social demographic, obstetrics and medical factors associated with thrombocYtopenia among women delivering at KIU-11I ................ 31
CHAPTER FIVE:· Discussion, Conclusions and Recommendations ........................................... 32
5.0 Introduction ............................................................... 32
5.1 Discussion., ................................................................... 32
5 .1 .1 The prevalence of thrombocytopenia among women delivering at KIU-11I ...................... 32
5.1.2 The relationship between immediate maternal complications and thrombocytopenia among women delivering at KIU-11! .............. 33
5.1.3 Social demographic, obstetrics and medical factors associated with thrombocytopenia among women delivering at KIU-TH ..... 34
5.3.3.1 Age ............................................................. 34
5.3.3.2 Hypertension in pregnancy ................................. 34
5.3.3.4 HIV· .................................................35
Gichungu, D (2022). Prevalence, Immediate Maternal Complications and Factors Associated with Thrombocytopenia among Women Delivering at Kampala International University Teaching Hospital, Western Uganda. Afribary. Retrieved from https://tracking.afribary.com/works/prevalence-immediate-maternal-complications-and-factors-associated-with-thrombocytopenia-among-women-delivering-at-kampala-international-university-teaching-hospital-western-uganda
Gichungu, David "Prevalence, Immediate Maternal Complications and Factors Associated with Thrombocytopenia among Women Delivering at Kampala International University Teaching Hospital, Western Uganda" Afribary. Afribary, 01 Oct. 2022, https://tracking.afribary.com/works/prevalence-immediate-maternal-complications-and-factors-associated-with-thrombocytopenia-among-women-delivering-at-kampala-international-university-teaching-hospital-western-uganda. Accessed 06 Nov. 2024.
Gichungu, David . "Prevalence, Immediate Maternal Complications and Factors Associated with Thrombocytopenia among Women Delivering at Kampala International University Teaching Hospital, Western Uganda". Afribary, Afribary, 01 Oct. 2022. Web. 06 Nov. 2024. < https://tracking.afribary.com/works/prevalence-immediate-maternal-complications-and-factors-associated-with-thrombocytopenia-among-women-delivering-at-kampala-international-university-teaching-hospital-western-uganda >.
Gichungu, David . "Prevalence, Immediate Maternal Complications and Factors Associated with Thrombocytopenia among Women Delivering at Kampala International University Teaching Hospital, Western Uganda" Afribary (2022). Accessed November 06, 2024. https://tracking.afribary.com/works/prevalence-immediate-maternal-complications-and-factors-associated-with-thrombocytopenia-among-women-delivering-at-kampala-international-university-teaching-hospital-western-uganda